Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Tenax Therapeutics, Inc. (TENX)

0.282   -0.003 (-1.05%) 08-18 05:42
Open: 0.2999 Pre. Close: 0.285
High: 0.31 Low: 0.26
Volume: 225,513 Market Cap: 7(M)
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.31 - 0.32 0.32 - 0.32
Low: 0.25 - 0.26 0.26 - 0.26
Close: 0.28 - 0.28 0.28 - 0.29

Technical analysis

as of: 2022-08-17 4:27:08 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.34     One year: 0.38
Support: Support1: 0.25    Support2: 0.2
Resistance: Resistance1: 0.29    Resistance2: 0.32
Pivot: 0.27
Moving Average: MA(5): 0.29     MA(20): 0.27
MA(100): 0.51     MA(250): 0.88
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 48.6     %D(3): 58
RSI: RSI(14): 41.7
52-week: High: 1.95  Low: 0.23
Average Vol(K): 3-Month: 208 (K)  10-Days: 134 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ TENX ] has closed below upper band by 45.5%. Bollinger Bands are 66.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 11 Aug 2022
Have $1.4 million? You could buy the Johnstown Galleria, now up for auction - TribDem.com

Tue, 09 Aug 2022
River North's Hotel Felix loan heads to auction - Crain's Chicago Business

Tue, 09 Aug 2022
Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Thu, 04 Aug 2022
What's Next for Very Bullish Rated TenX (PAY)? - InvestorsObserver

Mon, 01 Aug 2022
StockNews.com Begins Coverage on Tenax Therapeutics (NASDAQ:TENX) - Defense World

Tue, 26 Jul 2022
Projects - Community engagement enhances urban spaces - LEDs Magazine

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 25 (M)
Shares Float 16 (M)
% Held by Insiders 36.2 (%)
% Held by Institutions 32 (%)
Shares Short 12 (K)
Shares Short P.Month 13 (K)

Stock Financials

EPS -0.5
EPS Est Next Qtl -0.08
EPS Est This Year -0.37
EPS Est Next Year -0.29
Book Value (p.s.) 0.05
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -158.2
Return on Equity (ttm) -487
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.42
Qtrly Earnings Growth 0
Operating Cash Flow -11 (M)
Levered Free Cash Flow -5 (M)

Stock Valuations

PE Ratio -0.58
PEG Ratio 0
Price to Book value 4.7
Price to Sales 0
Price to Cash Flow -0.68

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2018-02-25
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.